Breast cancer and ATM mutations: treatment implications
Abstract Genetic testing for breast cancer predisposing genes has expanded beyond BRCA1 and BRCA2 and now includes panels of 20 or more genes. It is now recommended that all women diagnosed with breast cancer at age 65 or below be offered testing for an extended gene panel. The rationale for testing...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2024-11-01
|
| Series: | Hereditary Cancer in Clinical Practice |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s13053-024-00300-9 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|